Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CLIP1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RPA1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
SOCS6 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
KIAA1217 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
DR1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
CUL5 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
PRDM9 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
TSN - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
PATL1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
KAT5 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
ZNF282 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
PDCD11 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GALNT10 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
RAB10 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GPSM2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
CELF1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GAB1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
YWHAZ - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
BAP1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
PRELID3B - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on